No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease

被引:29
|
作者
Sodeyama, N
Yamada, M
Itoh, Y
Suematsu, N
Matsushita, M
Otomo, E
Mizusawa, H
机构
[1] Tokyo Med & Dent Univ, Dept Neurol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Yokufukai Geriatr Hosp, Dept Internal Med, Tokyo, Japan
[3] Yokufukai Geriatr Hosp, Dept Pathol, Tokyo, Japan
[4] Tokyo Inst Psychiat, Dept Neuropathol, Tokyo, Japan
关键词
AD; paraoxonase; polymorphism; neuropathologic change;
D O I
10.1212/WNL.53.5.1146
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Both AD and paraoxonase (PON) have been reported to be related to lipids and atherosclerosis, suggesting that the PON gene (PON) is a possible genetic risk factor for AD. We found no association of PON polymorphism with severity of atherosclerosis, densities of AD-type, neuropathologic change, or development of AD in 47 AD and 90 nondemented patients. Our study suggests that PON polymorphism does not play a. causal role in the development of atherosclerosis or AD.
引用
收藏
页码:1146 / 1148
页数:3
相关论文
共 50 条
  • [1] Paraoxonase Gene Polymorphism and the Risk for Alzheimer's Disease in the Polish Population
    Klimkowicz-Mrowiec, A.
    Marona, M.
    Wolkow, P.
    Witkowski, A.
    Maruszak, A.
    Styczynska, M.
    Barcikowska, M.
    Szczudlik, A.
    Slowik, A.
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (06) : 417 - 423
  • [2] Association analysis of the paraoxonase-1 gene with Alzheimer's disease
    Cellini, Elena
    Tedde, Andrea
    Bagnoli, Silvia
    Nacmias, Benedetta
    Piacentini, Silvia
    Bessi, Valentina
    Bracco, Laura
    Sorbi, Sandro
    [J]. NEUROSCIENCE LETTERS, 2006, 408 (03) : 199 - 202
  • [3] Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease
    Chapuis, Julien
    Boscher, Maud
    Bensemain, Faiza
    Cottel, Dominique
    Amouyel, Philippe
    Lambert, Jean-Charles
    [J]. NEUROBIOLOGY OF AGING, 2009, 30 (01) : 152 - 156
  • [4] Association of a cathepsin D gene polymorphism with Alzheimer's disease
    Papassotiropoulos, A
    Bagli, M
    Jessen, F
    Ludwig, M
    Rao, ML
    Maier, W
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 : 230S - 230S
  • [5] Association of paraoxonase 1 polymorphism with Alzheimer's disease and increased plasma levels of oxidized LDL
    Zambon, A.
    Mercurio, D.
    Zarantone, G.
    Leon, A.
    Vianello, D.
    Battistin, L.
    Cagnin, A. C.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 53 - 54
  • [6] No association between promoter polymorphism of the MAOA gene and Alzheimer's disease
    Juhasz, A.
    Feher, A.
    Rimanoczy, A.
    Galfi, M.
    Kalman, J.
    Janka, Z.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S119 - S120
  • [7] No association between tryptophan hydroxylase gene polymorphism and Alzheimer's disease
    Wang, YC
    Tsai, SJ
    Liu, TY
    Liu, HC
    Hong, CJ
    [J]. NEUROPSYCHOBIOLOGY, 2001, 43 (01) : 1 - 4
  • [8] Association between Alzheimer's disease and a functional polymorphism in the myeloperoxidase gene
    Crawford, FC
    Freeman, MJ
    Schinka, JA
    Morris, MD
    Abdullah, LI
    Richards, D
    Sevush, S
    Duara, R
    Mullan, MJ
    [J]. EXPERIMENTAL NEUROLOGY, 2001, 167 (02) : 456 - 459
  • [9] Alzheimer's disease and the cystatin C gene polymorphism:: an association study
    Beyer, K
    Lao, JI
    Gómez, M
    Riutort, N
    Latorre, P
    Mate, JL
    Ariza, A
    [J]. NEUROSCIENCE LETTERS, 2001, 315 (1-2) : 17 - 20
  • [10] Genetic association of paraoxonase 1 polymorphisms with Alzheimer's disease
    Cagnin, A.
    Zambon, A.
    Lunardelli, V.
    Zarantonello, G.
    Leon, A.
    Battistin, L.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 255 - 255